Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test
Population screening has improved early diagnosis of colorectal cancer (CRC). Nonetheless, most cases are diagnosed in symptomatic patients. Faecal immunochemical testing has been recommended for assessing patients with lower gastrointestinal symptoms, but whether it improves patient survival is unk...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/9/2412 |
id |
doaj-35dd6b8a9fd74401b88d037e6a9fc222 |
---|---|
record_format |
Article |
spelling |
doaj-35dd6b8a9fd74401b88d037e6a9fc2222020-11-25T03:57:23ZengMDPI AGCancers2072-66942020-08-01122412241210.3390/cancers12092412Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical TestMaría Angeles Gutierrez-Stampa0Vanessa Aguilar1Cristina Sarasqueta2Joaquín Cubiella3Isabel Portillo4Luis Bujanda5Altza Primary Care Health Center, OSI Donostialdea; Biodonostia Health Research Institute, 20014 San Sebastián, SpainAltza Primary Care Health Center, OSI Donostialdea; Biodonostia Health Research Institute, 20014 San Sebastián, SpainBiodonostia Health Research Institute, Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Hospital Universitario Donostia, 20014 San Sebastian, SpainGastroenterology Department, Complexo Hospitalario Universitario de Ourense, 32005 Ourense, SpainColorectal Cancer Screening Programme, Osakidetza, Basque Health Service, 48010 Bilbao, SpainGastroenterology Department, Osakidetza, Hospital Universitario Donostia, Biodonostia Health Research Institute, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), University of the Basque Country (UPV/EHU), 20014 San Sebastián, SpainPopulation screening has improved early diagnosis of colorectal cancer (CRC). Nonetheless, most cases are diagnosed in symptomatic patients. Faecal immunochemical testing has been recommended for assessing patients with lower gastrointestinal symptoms, but whether it improves patient survival is unknown. Our objective was to compare CRC survival in 50- to 69-year-olds between asymptomatic screen-detected patients and symptomatic patients by route to diagnosis. Methods: We identified all cases of CRC diagnosed in 50-to 69-year-olds between 2009 and 2016, in Donostialdea (Gipuzkoa, Spain). Three groups were created: 1-screen-detected CRC; 2-CRC detected in symptomatic patients after a positive faecal immunochemical test(FIT); and 3-CRC detected in symptomatic patients without a FIT or after a negative result. We analysed survival using the Kaplan-Meier method and log-rank tests. Results: Of 930 patients diagnosed with CRC, 433 cases were detected through screening and 497 in symptomatic patients, 7.9% after a positive FIT and 45.5% by other means. The 3-year CRC survival was significantly lower in group 3 (69.5%) than groups 1 (93%; <i>p</i> = 0.007) or 2 (87.5%; <i>p</i> = 0.02). The risk of death was lower in groups 1 (HR 0.42, 95% CI 0.30–0.58) and 2 (HR 0.51; 95% CI 0.29–0.87). Conclusion: Half of CRC cases in 50- to 69-year-olds are diagnosed outside screening. Use of the FIT as a diagnostic strategy in symptomatic patients may improve survival.https://www.mdpi.com/2072-6694/12/9/2412colorectal cancerfaecal immunochemical testsurvival |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
María Angeles Gutierrez-Stampa Vanessa Aguilar Cristina Sarasqueta Joaquín Cubiella Isabel Portillo Luis Bujanda |
spellingShingle |
María Angeles Gutierrez-Stampa Vanessa Aguilar Cristina Sarasqueta Joaquín Cubiella Isabel Portillo Luis Bujanda Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test Cancers colorectal cancer faecal immunochemical test survival |
author_facet |
María Angeles Gutierrez-Stampa Vanessa Aguilar Cristina Sarasqueta Joaquín Cubiella Isabel Portillo Luis Bujanda |
author_sort |
María Angeles Gutierrez-Stampa |
title |
Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test |
title_short |
Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test |
title_full |
Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test |
title_fullStr |
Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test |
title_full_unstemmed |
Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test |
title_sort |
colorectal cancer survival in 50- to 69-year-olds after introducing the faecal immunochemical test |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2020-08-01 |
description |
Population screening has improved early diagnosis of colorectal cancer (CRC). Nonetheless, most cases are diagnosed in symptomatic patients. Faecal immunochemical testing has been recommended for assessing patients with lower gastrointestinal symptoms, but whether it improves patient survival is unknown. Our objective was to compare CRC survival in 50- to 69-year-olds between asymptomatic screen-detected patients and symptomatic patients by route to diagnosis. Methods: We identified all cases of CRC diagnosed in 50-to 69-year-olds between 2009 and 2016, in Donostialdea (Gipuzkoa, Spain). Three groups were created: 1-screen-detected CRC; 2-CRC detected in symptomatic patients after a positive faecal immunochemical test(FIT); and 3-CRC detected in symptomatic patients without a FIT or after a negative result. We analysed survival using the Kaplan-Meier method and log-rank tests. Results: Of 930 patients diagnosed with CRC, 433 cases were detected through screening and 497 in symptomatic patients, 7.9% after a positive FIT and 45.5% by other means. The 3-year CRC survival was significantly lower in group 3 (69.5%) than groups 1 (93%; <i>p</i> = 0.007) or 2 (87.5%; <i>p</i> = 0.02). The risk of death was lower in groups 1 (HR 0.42, 95% CI 0.30–0.58) and 2 (HR 0.51; 95% CI 0.29–0.87). Conclusion: Half of CRC cases in 50- to 69-year-olds are diagnosed outside screening. Use of the FIT as a diagnostic strategy in symptomatic patients may improve survival. |
topic |
colorectal cancer faecal immunochemical test survival |
url |
https://www.mdpi.com/2072-6694/12/9/2412 |
work_keys_str_mv |
AT mariaangelesgutierrezstampa colorectalcancersurvivalin50to69yearoldsafterintroducingthefaecalimmunochemicaltest AT vanessaaguilar colorectalcancersurvivalin50to69yearoldsafterintroducingthefaecalimmunochemicaltest AT cristinasarasqueta colorectalcancersurvivalin50to69yearoldsafterintroducingthefaecalimmunochemicaltest AT joaquincubiella colorectalcancersurvivalin50to69yearoldsafterintroducingthefaecalimmunochemicaltest AT isabelportillo colorectalcancersurvivalin50to69yearoldsafterintroducingthefaecalimmunochemicaltest AT luisbujanda colorectalcancersurvivalin50to69yearoldsafterintroducingthefaecalimmunochemicaltest |
_version_ |
1724461216055689216 |